Description de l'entreprise
Medios AG, along with its subsidiaries Medios Pharma GmbH and Medios Manufaktur GmbH, has positioned itself in the specialty pharma segment as the go-to source for expertise and solutions. It brings together individual market players in a network of cooperating partners. Specialty pharmaceutical drugs are medications for patients with rare and/or chronic illnesses (for example, cancer, autoimmune diseases, and infectious diseases) that require lengthy and expensive treatment. Medios AG buys, sells and manages investments of innovative companies. The company aims to establish a strategic investment portfolio and to support its governance.
Conseil d'administration & Conseil de surveillance
| PDG |
| Matthias Gärtner |
| Conseil d'administration |
| Falk Neukirch, Christoph Prußeit, Mi-Young Miehler, Constantijn van Rietschoten |
| Conseil de surveillance |
| Dr. Yann Samson, Joachim Messner, Dr. Anke Nestler, Klaus Buß |
Données de l'entreprise
| Nom: |
Medios AG |
| Adresse: |
Friedrichstraße 113a,D-10117 Berlin |
| Téléphone: |
+49 30 232 566 800 |
| Fax: |
+49 30 232 566 800 |
| Courriel: |
info@medios.ag
|
| Internet: |
www.medios.ag |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
58.50% |
| IPO date: |
15/07/1999 |
Relations avec les investisseurs
| Nom: |
Claudia Nickolaus |
| Téléphone IR: |
+49 30 232 566 800 |
| IR-Fax: |
- |
| E-mail IR: |
ir@medios.ag
|
